FWM
COCP icon

Focused Wealth Management’s Cocrystal Pharma COCP Stock Holding History

Focused Wealth Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21
Closed – – 942
2022
Q1 		$0 Hold
21
– – ﹤0.01% 998
2021
Q4 		$0 Hold
21
– – ﹤0.01% 999
2021
Q3 		$0 Hold
21
– – ﹤0.01% 1008
2021
Q2 		$0 Hold
21
– – ﹤0.01% 941
2021
Q1 		$0 Sell
21
-12
-36% -$244 ﹤0.01% 916
2020
Q4 		$1K Buy
+33
New +$458 ﹤0.01% 767

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Focused Wealth Management's COCP Position: Q2 2022 in Review

Focused Wealth Management sold out of Cocrystal Pharma (COCP) in Q2 2022, closing a stake of 21 shares.

Focused Wealth Management first reported a position in COCP in Q4 2020 and held it in 6 quarters. The position peaked at $1K in Q4 2020. 33 funds tracked by Wall St. Rank hold COCP as of Q2 2022.

  • Focused Wealth Management reported no remaining Cocrystal Pharma position as of Q2 2022 after selling out during the quarter.
  • Focused Wealth Management sold 21 Cocrystal Pharma shares in Q2 2022.
  • Focused Wealth Management first reported a position in Cocrystal Pharma in Q4 2020 and held it in 6 quarters.
  • Focused Wealth Management's Cocrystal Pharma position peaked at $1K in Q4 2020.
  • 33 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2022.

Based on Focused Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.